Literature DB >> 14977437

Effects of flavonoid-rich beverages on prostacyclin synthesis in humans and human aortic endothelial cells: association with ex vivo platelet function.

John A Polagruto1, Derek D Schramm, Janice F Wang-Polagruto, Luke Lee, Carl L Keen.   

Abstract

Diets rich in flavonoids have been associated with reduced risk for cardiovascular disease. This may be due, in part, to flavonoid-induced alterations in eicosanoid synthesis. Our objective was to identify plant-derived beverages that alter synthesis of prostacyclin in cultured human aortic endothelial cells (HAEC), and to determine if these beverages could alter in vivo 6-keto-prostaglandin F(1alpha) (a stable metabolite of prostacyclin) synthesis and platelet function. HAEC were treated with nine commonly consumed beverages to determine their effects on prostacyclin synthesis under acute and chronic treatment regimens. Orange, purple grape, and pomegranate juices and coffee (6-9 mL/kg) were then provided to 28 fasted, healthy adult subjects (eight men and 20 women) on five separate days. Plasma samples were collected immediately following juice consumption (baseline), and at 2 and 6 hours post-consumption. On an acute basis, administration of HAEC with pomegranate juice increased media prostacyclin. Chronic exposure to purple grape and pomegranate juice increased aortic endothelial cell prostacyclin synthesis (38% and 61%, respectively; P <.05). The consumption of purple grape, pomegranate, and orange juice prolonged epinephrine/collagen-induced clotting time (P <.05). Purple grape juice increased plasma 6-keto-prostaglandin F(1alpha) (20%; P <.05) at 2 hours; pomegranate and orange juice did not significantly influence plasma prostacyclin concentrations. Consistent with the in vitro data, coffee consumption did not influence clotting time or plasma prostacyclin concentrations. These results indicate that the HAEC model system can provide a qualitative means to screen food and food-derived products for biologic activity related to cardiovascular health.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14977437     DOI: 10.1089/109662003772519840

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  7 in total

1.  Protective effects of luteolin on the venous endothelium.

Authors:  Henrique Charlanti Reis Assunção; Yan Milen Coelho Cruz; Jéssica Silva Bertolino; Raphael Caio Tamborelli Garcia; Liliam Fernandes
Journal:  Mol Cell Biochem       Date:  2021-01-19       Impact factor: 3.396

2.  Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo.

Authors:  S Mosawy; D E Jackson; O L Woodman; M D Linden
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

3.  Steam-cooking rapidly destroys and reverses onion-induced antiplatelet activity.

Authors:  Emilie A Hansen; John D Folts; Irwin L Goldman
Journal:  Nutr J       Date:  2012-09-20       Impact factor: 3.271

4.  COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood.

Authors:  Piet Borgdorff; M Louis Handoko; Yeun Ying Wong; Geert Jan Tangelder
Journal:  Open Cardiovasc Med J       Date:  2010-10-21

5.  Pomegranate Supplementation Protects against Memory Dysfunction after Heart Surgery: A Pilot Study.

Authors:  Susan A Ropacki; Sapna M Patel; Richard E Hartman
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-16       Impact factor: 2.629

6.  Pomegranate Supplementation Accelerates Recovery of Muscle Damage and Soreness and Inflammatory Markers after a Weightlifting Training Session.

Authors:  Achraf Ammar; Mouna Turki; Hamdi Chtourou; Omar Hammouda; Khaled Trabelsi; Choumous Kallel; Osama Abdelkarim; Anita Hoekelmann; Mohamed Bouaziz; Fatma Ayadi; Tarak Driss; Nizar Souissi
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 7.  Synthetic Flavonoids as Novel Modulators of Platelet Function and Thrombosis.

Authors:  Thomas M Vallance; Divyashree Ravishankar; Dina A I Albadawi; Helen M I Osborn; Sakthivel Vaiyapuri
Journal:  Int J Mol Sci       Date:  2019-06-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.